“Through prior authorization, insurance companies create barriers to treatment—and even the sickest patients aren’t spared from this ordeal.
“Of all the patients and all the conditions that we care for, cancer patients are probably some of the ones for whom the delays and the denials and the claim of ‘that’s experimental’ has probably the greatest impact,” AMA President Bruce A. Scott, MD, said while moderating a panel discussion on prior authorization at the 2025 AMA State Advocacy Summit held last month in Carlsbad, California.”
Leave a Reply